16:55 EST Cellectar Biosciences (CLRB) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLRB:
- Cellectar Biosciences transferred with Buy rating at Ladenburg
- Cellectar Biosciences price target lowered to $12 from $14 at Oppenheimer
- Cellectar Biosciences Reports Q3 2024 Financial Results
- Cellectar Biosciences reports Q3 EPS (40c), consensus (37c)
- Cellectar Biosciences sees cash runway into 2Q25